Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #220521 on Biotech Values
DewDiligence
08/17/18 11:41 AM
#220526 RE: jbog #220521
03/08/23 4:30 PM
#245781 RE: jbog #220521
The so-called Netflix-like subscription model would see the federal government spend a fixed amount on [HCV] drugs, likely in the billions as it costs an average of $24,000 per 12-week course, and then gain access to an unlimited number of pills to treat and cure as many with hepatitis C as possible. The move — which [NIH Director] Collins said has the support of both Gilead and AbbVie… would also need to come up with a plan to find out who exactly has the virus, as Collins noted that more than 40% of people who have it don’t know that they do. …Speaking on last night’s panel alongside Collins was another proponent of a major move to cure more hep C cases, ranking member of the Senate health committee, Sen. Bill Cassidy (R-LA), who discussed the Netflix-like subscription model he helped stand up in his home state to increase access to the cures (#msg-142973444). A ramp-up of usage will go a long way to saving money from liver transplants and other end-of-life care, the panelists noted.